Kopran Ltd.

Financial

	Kopran	SMS Lifesciences	RPG Life Sciences
Operational Metrics
Financials
5 yr Average ROE	14.2 %	11.9 %	20.08 %
5yr average Equity Multiplier	1.74	2.39	1.4
5yr Average Asset Turnover Ratio	0.95	1.0	1.26
5yr Avg Net Profit Margin	8.56 %	4.92 %	11.59 %
Price to Book	2.47	1.46	7.1
P/E	23.81	28.34	30.35
5yr Avg Cash Conversion Cycle	104.91 Days	-18.6 Days	-64.92 Days
Inventory Days	81.99 Days	79.26 Days	63.34 Days
Days Receivable	94.82 Days	40.71 Days	25.32 Days
Days Payable	82.13 Days	141.19 Days	145.09 Days
5yr Average Interest Coverage Ratio	9.39	4.88	17.66
5yr Avg ROCE	19.06 %	13.21 %	27.52 %
5yr Avg Operating Profit Margin	15.55 %	10.6 %	19.94 %
5 yr average Debt to Equity	0.33	0.52	0.02
5yr CAGR Net Profit	2.54 %	-8.48 %	24.75 %
5yr Average Return on Assets	8.15 %	4.94 %	14.44 %
Shareholdings
Promoter Holding	44.49 %	71.19 %	72.81 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.71 %	2.93 %	0.74 %
Change in Mutual Fund Holding (3 Yrs)	0.94 %	0.0	1.47 %

Business

	Kopran	SMS Lifesciences	RPG Life Sciences
Product Wise Break-Up	Product Wise Break-Up API 54.3 Formulations 45.7 API`S 0 0 International Formulations 0 Domestic Formulations 0	Product Wise Break-Up Domestic Formulations 0 API 0 0 Formulations 0 International Formulations 0 API`S 0 Others 100	Product Wise Break-Up Domestic Formulations 67.0 API 0 Active Pharmaceutical Ingredient (API) 15.0 Formulations 0 International formulations 18.0 API`S 0
Location Wise Break-Up	Location Wise Break-Up India 28.53 South Africa 20.39 Jordan 9.92 Ethiopia 5.87 UK 2.88 Mexico 0.96 Germany 0.85 Zambia 0.8 Tanzania 0.48 Switzerland 0.04 Turkey 0 Egypt 0 Rest of the World 0 Others 29.28	Location Wise Break-Up Ethiopia 0 UK 0 Germany 0 Switzerland 0 Turkey 0 Rest of the World 40.29 Jordan 0 South Africa 0 Mexico 0 Tanzania 0 Egypt 0 Zambia 0 India 59.41 Others 0.3	Location Wise Break-Up Ethiopia 0 UK 0 Germany 0 Switzerland 0 Turkey 0 Rest of the World 33.45 Jordan 0 South Africa 0 Mexico 0 Tanzania 0 Egypt 0 Zambia 0 India 66.55
Dosage Form Break-Up	Dosage Form Break-Up Bulk Chemicals 46.0 Tablet 45.93 Others 8.07	-	-
Asset Break-Up	Asset Break-Up India 99.98 Hong Kong 0.02	-	-